Allopurinol Teva 100 mg tablets
Authorisation PA0749/099/001 · Teva Pharma B.V.
- Licence holder
- Teva Pharma B.V. (all products →)
- Active substance
- Allopurinol
- Clinical trials
- 6 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- M04AA, M04AA01
- First authorised
- 10/09/2010
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Allopurinol: supply and approvals
13 authorised products on the HPRA list contain Allopurinol. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- Allopurinol Tablet: resolved, updated 19 Feb 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 16 years (since 10 September 2010). The HPRA list marks it as marketed in Ireland.
Other medicines with Allopurinol in Ireland
12 other products on the HPRA list contain Allopurinol, from 5 licence holders; 8 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Allopurinol 100 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Allopurinol 300 mg tablets | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Allopurinol Teva 300 mg tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Alopur 100 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Alopur 300 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Tipuric 100 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Tipuric 300 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Zyloric 300 mg tablets | Aspen Pharma Trading Limited | National authorisation (PA) | Marketed |
| Allopurinol Clonmel 100 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Allopurinol Clonmel 200 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Allopurinol Clonmel 300 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Not marketed |
| Zyloric 100 mg tablets | Aspen Pharma Trading Limited | National authorisation (PA) | Not marketed |
Other substances in ATC group M04AA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 1 other active substance shares the group M04AA with this product:
Febuxostat (10)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Teva Pharma B.V. holds 155 products on the HPRA list, with 69 different active substances; 100 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.